Quarterly report pursuant to Section 13 or 15(d)

EQUITY METHOD INVESTMENT IN PROGRESSIVE CARE, INC. AND SUBSIDIARIES (Tables)

v3.22.2.2
EQUITY METHOD INVESTMENT IN PROGRESSIVE CARE, INC. AND SUBSIDIARIES (Tables)
9 Months Ended
Sep. 30, 2022
Equity Method Investments and Joint Ventures [Abstract]  
SCHEDULE OF DESCRIPTION EQUITY METHOD INVESTMENT

The following summarizes the Company’s condensed consolidated balance sheet description equity method investment as follows:

 

    Carrying Amount  
August 30, 2022, beginning balance   $ 7,000,000  
Portion of income from Progressive Care, Inc. and Subsidiaries     (3,453,172 )
Depreciation expense due to cost basis difference (1)     (8,258 )
Interest earned from convertible note receivable     5,056  
Interest earned from amortization of premium on convertible note receivable     3,621  
Elimination of intercompany interest earned     (1,683 )
September 30, 2022, carrying amount     3,545,564  
Equity method investment – short term     (5,056 )
Equity method investment – long term   $ 3,540,508  

 

The following summarizes the Company’s condensed consolidated statements of operations and comprehensive loss description equity in net loss of affiliate for the three and nine months ended September 30, 2022 as follows:

 

 

   

For the Three and Nine Months Ended

September 30, 2022

 
Equity in net loss of affiliate   $ (3,453,172 )
         
Depreciation expense due to cost basis difference (1)     (8,258 )
Interest earned from convertible note receivable     5,056  
Interest earned from amortization of premium on convertible note receivable     3,621  
Elimination of intercompany interest earned     (1,683 )
Equity in net loss of affiliate   $ (3,454,436 )

 

(1) NextPlat records depreciation expense on its estimated cost basis difference which is subject to change